Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-10-15

FDA Approved: CLONAZEPAM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for clonazepam filed by Teva Pharmaceuticals USA, Inc., indicating an update under the approved application.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • KLONOPIN (clonazepam)

Snippet

SUPPL AP for CLONAZEPAM (CLONAZEPAM)